Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsJNDOF +68.92%96 Return-on-Tangible-Asset is 15.40% as of Feb. 2026, which is 70% above its 10-year median of 9.06. GuruFocus rates JNDOF with a GF Score™ of 96/100 and a GF Value™ of $42.68. Among 857 Medical Devices & Instruments companies, JINS Holdings ranks better than 93% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. JINS Holdings's annualizedNet Income for the quarter that ended in Feb. 2026 was $49.8 Mil. JINS Holdings's average total tangible assets for the quarter that ended in Feb. 2026 was $323.2 Mil. Therefore, JINS Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Feb. 2026 was 15.40%.
The historical rank and industry rank for JINS Holdings's Return-on-Tangible-Asset or its related term are showing as below:
JNDOF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 1.45 Med: 9.06 Max: 16.07
Current: 15.93
During the past 13 years, JINS Holdings's highest Return-on-Tangible-Asset was 16.07%. The lowest was 1.45%. And the median was 9.06%.
JNDOF's Return-on-Tangible-Asset is ranked better than 93% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.57
vs JNDOF: 15.93
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
JINS Holdings Return-on-Tangible-Asset Related Terms
JINS Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for JINS Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JNDOF vs ISRG, BDX, MDLN: Return-on-Tangible-Asset Comparison
For the Medical Instruments & Supplies subindustry, JINS Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where JINS Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Feb. 2026) net income data.
What does a Return-on-Tangible-Asset of 15.40% mean?
JINS Holdings (JNDOF) has a Return-on-Tangible-Asset of 15.40% as of Feb. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on JINS Holdings and its competitors. This is 70% above median its historical median of 9.06. Over the past decade, JINS Holdings' Return-on-Tangible-Asset has ranged from 1.45 to 16.07. According to the industry distribution chart, JINS Holdings ranks #60 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 7%.
Is JINS Holdings' Return-on-Tangible-Asset too high?
JINS Holdings' current Return-on-Tangible-Asset of 15.40% is 70% above median its 10-year median of 9.06. Over the past 10 years, this metric has ranged from a low of 1.45 to a high of 16.07. The Medical Devices & Instruments industry median Return-on-Tangible-Asset is 0.57. JINS Holdings' value of 15.40% is 2601.8% above this industry median. Based on the distribution chart, JINS Holdings ranks #60 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' Return-on-Tangible-Asset compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #60 out of 857 companies for Return-on-Tangible-Asset. This places JINS Holdings in the top 7% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 0.57. JINS Holdings' value of 15.40% is 2601.8% above this benchmark. Historically, JINS Holdings' own Return-on-Tangible-Asset has ranged from 1.45 to 16.07 over the past decade. While the company's 10-year median is 9.06 vs. the industry median of 0.57, JINS Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.57, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current Return-on-Tangible-Asset of 15.40% is 2601.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current Return-on-Tangible-Asset is 15.40%, which is 70% above median its own 10-year median of 9.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
JINS Holdings (JNDOF) has a current Return-on-Tangible-Asset of 15.40%. The stock's GF Value™ is $42.68, compared to a current price of $38.43 — trading 10% below its estimated fair value. The current Return-on-Tangible-Asset is 15.40%, which is 70% above median its 10-year median of 9.06 and 2601.8% above the Medical Devices & Instruments industry median of 0.57. JINS Holdings' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For JINS Holdings (JNDOF), the current Return-on-Tangible-Asset is 15.40% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (JNDOF) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of $38.43 is trading 10% below its estimated GF Value™ of $42.68.
Key valuation signals for JNDOF:
Return-on-Tangible-Asset: 15.40% (70% above median its 10-year median of 9.06)
GF Value™: $42.68 vs. price of $38.43 (10% below fair value)
Industry Position: 2601.8% above the Medical Devices & Instruments median (#60 of 857)
No single metric tells the full story. See the JNDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
96GF Score
Get the complete analysis for JNDOF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JNDOF has been successfully added to your 
